Q Fever (Coxiella burnetii) & Agricultural Zoonoses in Regional Victoria

Agricultural Exposure in the Goulburn Valley

The Goulburn Valley is one of Australia's most productive agricultural and dairy food bowls. Consequently, local general practitioners regularly encounter occupational zoonotic infections, foremost among which is Q Fever, caused by the obligate intracellular bacterium Coxiella burnetii.

• Reservoirs & Extreme Environmental Resilience: Cattle, sheep, and goats are the primary domestic reservoirs, alongside feral kangaroos. C. burnetii forms spore-like 'small cell variants' that survive in dry soil and dust for months or years, resisting desiccation, heat, and standard disinfectants.
• Parturient Transmission: Millions of infectious organisms are shed in the amniotic fluid, placenta, foetal membranes, milk, and urine during animal birth (calving, lambing, kidding).
• Aerosol Inhalation: The organism is exceptionally infectious; inhalation of a single organism in wind-borne dust can cause clinical infection. Transmission occurs not only to direct animal handlers, but to individuals living downwind of farms, saleyards, abattoirs, or transport routes.

Clinical Spectrum: Acute vs Chronic Disease

The incubation period ranges from 2 to 4 weeks:

• Acute Q Fever: Severe, abrupt onset of high swinging fevers, rigors, profuse drenching night sweats, profound fatigue, and an incapacitating retro-orbital headache with photophobia. Associated with acute hepatitis (transaminitis), atypical pneumonia (dry cough, chest pain), or profound post-Q fever chronic fatigue syndrome (QFS) lasting for months or years.
• Chronic Q Fever: Develops months to years later, manifesting as insidious, culture-negative infective endocarditis, vascular graft infection, osteomyelitis, or chronic hepatitis. Diagnosis is confirmed by elevated Phase I IgG antibody titres (≥ 1:800).

Laboratory Diagnosis & First-Line Treatment

Standard blood cultures are negative. Diagnosis requires targeted testing:

• Early Phase (< 2 weeks of illness): Whole-blood or serum PCR for C. burnetii DNA is the most sensitive test before antibody seroconversion occurs.
• Late Phase (> 2 weeks of illness): Indirect Immunofluorescence Assay (IFA) demonstrating seroconversion with elevated Phase II IgM and IgG antibodies.
• First-Line Pharmacotherapy: Doxycycline 100 mg orally twice daily for 14 days. Commencing doxycycline within the first 3 days of symptom onset significantly shortens fever duration and prevents progression to chronic sequelae.

Pre-Vaccination Screening & Q-Vax Administration

Australia is the only nation with a licensed, highly protective whole-cell inactivated Q fever vaccine: Q-Vax. It confers > 95% long-lasting protection for meatworkers, dairy farmers, shearers, vets, and agricultural students.

MANDATORY PRE-VACCINATION SCREENING PROTOCOL: Vaccinating an individual with prior natural exposure to C. burnetii can trigger severe, necrotising local skin reactions and systemic hypersensitivity. Before vaccination, two mandatory screening tests must be performed simultaneously:

1. Serum Q Fever Antibody Serology (IFA): Evaluating past immunological exposure.
2. Q-Vax Diluted Intradermal Skin Test: 0.1 mL injected intradermally into the volar forearm. The patient returns exactly 7 days later for formal skin inspection.

Only if both the serology is negative AND the 7-day skin test is completely negative (no erythema, induration, or nodule) can the full subcutaneous Q-Vax dose be safely administered.